"With the COVID pandemic behind us, it is time to adopt a common-sense approach to COVID policy," a spokesperson for the FDA ...

It’s been five years since the start of the COVID-19 Pandemic, and tens of millions of people have still not fully recovered from the virus.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into ...

Rather, it is the complex interactions between pupil absence and exclusions, the ongoing impacts on children with special ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

UT is heralded as a research powerhouse in Texas, exceeding $1 billion in total research expenditures last year.

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...